Skip to main content
Premium Trial:

Request an Annual Quote

Hayden Jeffreys

ERBA Diagnostics has appointed Hayden Jeffreys as interim CEO, effective Jan. 1, 2017. The employment agreement of the company's current CEO Mohan Gopalkrishnan expires on Dec. 31. Jeffreys has served on ERBA's board of directors since May 31, and also serves as the commercial director for the molecular diagnostics division and as vice president of business development and strategy for ERBA Diagnostics Mannheim. He plans to continue in those capacities. Prior to joining ERBA Mannheim, Jeffreys served in a variety of positions for several diagnostics companies, including Lumora, Lab21 Healthcare, Invitron, Kronus, and Gen-Probe UK (now Hologic).

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.